TABLE 5.

Baseline characteristics and outcomes of included patients which received leukapheresis

	Oncologic
First author	Atas, Avci, Castagnetti (n = 2), Clark, Mishra, Manuel, Morano, Ponniah, Shaeer, Swapna, Veljkovic
No. of patients studied	12
Age (years)	17.3 (±4.7)
WBC count, ×109/L	365 (±193)
Time to treatment in days	3 (1, 2, 3, 4, 5)
Resolution, yes	10 (83.3%) NB: 8.3% missing
Erectile dysfunction, yes	2 (16.7%) NB: 58% missing

Note: Numbers (% of total number patients) unless otherwise specified. Parameters are presented as mean ± standard deviation when normally distributed, or as mean (Quartile 1–Quartile 3) when not normal distributed.